| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 1,8 M € | -10.4% | 2,0 M € | -1.9% | 2,0 M € | -36.1% | 3,2 M € | +123.7% | 1,4 M € | +2.0% | 1,4 M € | -2.7% | 1,4 M € | +17.9% | 1,2 M € | +24.3% | 969,5 k € | +18.6% | 817,5 k € | +32.1% | 618,9 k € | -13.8% | 717,7 k € | +40.0% | 512,6 k € | +7.3% | 477,6 k € | +18.6% | 402,7 k € | -10.3% | 449,1 k € | +170.2% | 166,2 k € | -79.1% | 794,0 k € | |
| EBITDA | 1,2 M € | -14.2% | 1,4 M € | +2.2% | 1,4 M € | -41.4% | 2,4 M € | +157.6% | 929,8 k € | +3.1% | 902,2 k € | -0.9% | 910,0 k € | +31.7% | 691,2 k € | +55.4% | 444,7 k € | +9.3% | 406,9 k € | +71.6% | 237,1 k € | -23.1% | 308,5 k € | +134.4% | 131,6 k € | -15.4% | 155,5 k € | -10.7% | 174,2 k € | +8.1% | 161,1 k € | +497.7% | -40,5 k € | -106.8% | 592,1 k € | |
| Operating profit | 1,2 M € | -15.6% | 1,4 M € | +6.3% | 1,3 M € | -43.4% | 2,3 M € | +170.8% | 846,5 k € | +8.5% | 780,0 k € | +8.6% | 718,0 k € | +25.6% | 571,6 k € | +72.6% | 331,1 k € | -28.3% | 461,8 k € | +221.6% | 143,6 k € | -23.2% | 186,8 k € | +599.4% | 26,7 k € | +136.2% | -73,8 k € | -264.2% | 44,9 k € | -32.0% | 66,1 k € | +141.0% | -161,0 k € | -131.0% | 519,6 k € | |
| Profit/loss | 899,1 k € | -16.5% | 1,1 M € | -5.9% | 1,1 M € | -28.6% | 1,6 M € | +157.4% | 622,4 k € | -1.1% | 629,4 k € | +7.9% | 583,5 k € | +41.7% | 411,8 k € | +95.0% | 211,2 k € | -26.0% | 285,5 k € | +108.5% | 136,9 k € | -24.2% | 180,6 k € | +234.5% | 54,0 k € | +201.8% | -53,1 k € | -208.4% | 48,9 k € | -25.6% | 65,7 k € | +149.5% | -132,8 k € | -127.1% | 489,7 k € | |
| Equity | 1,5 M € | -16.8% | 1,8 M € | -57.4% | 4,2 M € | -15.4% | 5,0 M € | +35.5% | 3,7 M € | +20.5% | 3,0 M € | +12.1% | 2,7 M € | +11.7% | 2,4 M € | +12.1% | 2,2 M € | +20.8% | 1,8 M € | +18.9% | 1,5 M € | -8.2% | 1,6 M € | -5.0% | 1,7 M € | +3.2% | 1,7 M € | -3.1% | 1,7 M € | +2.9% | 1,7 M € | +4.1% | 1,6 M € | -7.6% | 1,7 M € | |
| Total assets | 3,2 M € | -5.1% | 3,3 M € | -34.8% | 5,1 M € | -9.2% | 5,6 M € | +37.6% | 4,1 M € | +10.8% | 3,7 M € | +11.2% | 3,3 M € | +2.6% | 3,2 M € | +13.6% | 2,8 M € | +13.1% | 2,5 M € | -1.8% | 2,6 M € | +6.6% | 2,4 M € | -5.8% | 2,6 M € | -8.7% | 2,8 M € | +25.6% | 2,2 M € | +7.3% | 2,1 M € | +18.4% | 1,8 M € | -25.2% | 2,3 M € | |
| Cash | 444,5 k € | -43.8% | 790,8 k € | +35.8% | 582,2 k € | -40.7% | 982,1 k € | -41.6% | 1,7 M € | +38.6% | 1,2 M € | +64.4% | 737,9 k € | -23.6% | 965,9 k € | +58.5% | 609,3 k € | +9.5% | 556,5 k € | -11.6% | 629,2 k € | +27.1% | 495,0 k € | -29.1% | 698,0 k € | -29.2% | 985,9 k € | -3.2% | 1,0 M € | -7.1% | 1,1 M € | +54.8% | 708,3 k € | -29.0% | 998,0 k € | |
| Debts | 1,7 M € | +8.5% | 1,5 M € | +70.6% | 902,8 k € | +37.5% | 656,5 k € | +55.4% | 422,4 k € | -34.7% | 646,8 k € | +7.3% | 603,0 k € | -17.2% | 728,1 k € | +7.4% | 677,8 k € | -6.0% | 721,2 k € | -31.5% | 1,1 M € | +39.1% | 756,4 k € | -7.5% | 817,5 k € | -25.9% | 1,1 M € | +140.7% | 458,7 k € | +30.4% | 351,9 k € | +205.0% | 115,4 k € | -79.4% | 559,1 k € | |
| Staff | 8,4 | 8,1 | 8,9 | 9,3 | 8,7 | 8,6 | — | 7,7 | 6,6 | 5,1 | 4,7 | 5,1 | 5,8 | 5,4 | 5,2 | 6,5 | 5,7 | 5,8 | ||||||||||||||||||
Private limited company · Genk · incorporated on 18/03/1988 · 8,4 ETP
Private limited company profitable and well capitalised. Cash position declining (-43.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Moovartes is a Private limited company incorporated in 1988. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Genk. It employs on average 8,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette